Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation
JAMA Dermatology · 01.02.2025 · 161 (2) · 216
DOI: 10.1001/jamadermatol.2024.5136 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.02.2025. Verfasst von Michela Starace und 29 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This retrospective case series compares vitiligo resulting from immune checkpoint inhibitor (ICI) therapy vs preexisting vitiligo among patients receiving ICI treatment for cancer.
Autor:innen und Institutionen
- Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
- Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
- Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
- Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of Dermatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
Zitieren
APA
Starace, M., Cedirian, S., Rapparini, L., Pileri, A., Carrera, C., Giavedoni, P., Alonso de Leon, M. T., Kraehenbuehl, L., Elshot, Y. S., Apalla, Z., Papegeorgiou, C., Nikolaou, V., Radevic, T., Lengyel, Z., Sollena, P., Peris, K., Rossi, E., Fattore, D., Koumaki, D., …, & Sibaud, V. (2025). Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation. JAMA Dermatology, 161(2), 216. https://doi.org/10.1001/jamadermatol.2024.5136
Vancouver
Starace M, Cedirian S, Rapparini L, Pileri A, Carrera C, Giavedoni P, et al. Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation. JAMA Dermatology. 2025;161(2):216. doi:10.1001/jamadermatol.2024.5136
BibTeX
@article{Starace2025,
author = {Starace, Michela and Cedirian, Stephano and Rapparini, Luca and Pileri, Alessandro and Carrera, Cristina and Giavedoni, Priscila and Alonso de Leon, M Teresa and Kraehenbuehl, Lukas and Elshot, Yannick S and Apalla, Zoe and Papegeorgiou, Chryssoula and Nikolaou, Vasiliki and Radevic, Tatjana and Lengyel, Zsuzsanna and Sollena, Pietro and Peris, Ketty and Rossi, Ernesto and Fattore, Davide and Koumaki, Dimitra and Boada, Aram and Forsea, Ana-Maria and Segura, Sonia and Freites-Martinez, Azael and Riganti, Julia and Avitan-Hersh, Emily and Saffuri, Nada and Peuvrel, Lucie and Dezoteux, Frédéric and Piraccini, Bianca Maria and Sibaud, Vincent},
title = {Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation},
journal = {JAMA Dermatology},
year = {2025},
volume = {161},
number = {2},
pages = {216},
doi = {10.1001/jamadermatol.2024.5136}
}
EUVIMED